Deborah C. Jackson Sells 42,202 Shares of American Well Co. (NYSE:AMWL) Stock

American Well Co. (NYSE:AMWL) Director Deborah C. Jackson sold 42,202 shares of the company’s stock in a transaction on Monday, June 24th. The stock was sold at an average price of $0.41, for a total transaction of $17,302.82. Following the transaction, the director now owns 636,683 shares in the company, valued at approximately $261,040.03. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

American Well Price Performance

AMWL opened at $0.38 on Friday. American Well Co. has a fifty-two week low of $0.35 and a fifty-two week high of $2.47. The company’s 50-day moving average is $0.46 and its 200 day moving average is $0.86. The firm has a market capitalization of $111.20 million, a P/E ratio of -0.30 and a beta of 1.07.

American Well (NYSE:AMWL) last announced its earnings results on Wednesday, May 1st. The company reported ($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.07). The business had revenue of $59.52 million during the quarter, compared to analysts’ expectations of $61.10 million. American Well had a negative return on equity of 46.76% and a negative net margin of 137.32%. During the same quarter in the previous year, the firm earned ($0.24) EPS. On average, equities research analysts expect that American Well Co. will post -0.75 earnings per share for the current year.

Institutional Investors Weigh In On American Well

A number of hedge funds have recently made changes to their positions in AMWL. Madison Park Capital Advisors LLC purchased a new stake in American Well during the fourth quarter worth about $34,000. Quadrature Capital Ltd purchased a new stake in shares of American Well during the 3rd quarter worth approximately $36,000. Oak Thistle LLC bought a new stake in shares of American Well in the 1st quarter worth approximately $46,000. Cito Capital Group LLC lifted its stake in American Well by 35.2% in the third quarter. Cito Capital Group LLC now owns 52,104 shares of the company’s stock valued at $61,000 after purchasing an additional 13,552 shares during the last quarter. Finally, RPO LLC bought a new position in American Well during the fourth quarter valued at $85,000. 56.05% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

AMWL has been the topic of a number of analyst reports. Morgan Stanley lowered their target price on shares of American Well from $1.75 to $1.00 and set an “equal weight” rating on the stock in a report on Monday, April 15th. Needham & Company LLC reissued a “hold” rating on shares of American Well in a research note on Thursday, May 2nd. Finally, UBS Group cut their target price on American Well from $1.50 to $0.60 and set a “neutral” rating on the stock in a research report on Thursday, May 23rd.

American Well Company Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.